In vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antimicrobials: Survey of Russian isolates

International Journal of Antimicrobial Agents

Volumn 7, Issue 2, 1996, Pages 109-117

  Sidorenko, Sergei V ^a   Rezvan, Svetlana P ^a   Tikchonova, Alexandra S ^a   Krotova, Larysa A ^a   Ansolis, Larysa E ^a   Tzvigun, Elena A ^a  

^a Natl Res Center for Antibiotics   (Russian Federation)

Author keywords

Ampicillin sulbactam; Antibiotics; Cefoperazone sulbactam; Susceptibility

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; SULBACTAM;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; USSR;

EID: 0030199044     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(96)00308-1     Document Type: Article

References (19)

1. [1] Baquero F, Reig M. Resistance of anaerobic bacteria to antimicrobial agents in Spain. Eur J Clin Microbiol Infect Dis 1991;11:1016-1020.
2. [2] Bush K. Characterization of β-lactamases. Antimicrob Agents Chemother 1989;33:.259-263.
3. [3] Bush K. Classification of β-lactamases: groups 1, 2a, 2b and 2b′. Antimicrob Agents Chemother 1989;33:264-270.
4. [4] Bush K. Classification of β-lactamases: groups 2c, 2d, 2e, 3 and 4. Antimicrob Agents Chemother 1989;33:271-276.
5. [5] Clark RB, Bartelt MA, Chan EL, Dalton HP. Multicenter study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents. J Antimicrob Chemother 1992;29:56-67.
6. [6] Cuchural GJ, Tally FP, Jacobus NV. Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother 1990;34:479-480.
7. [7] English AR, Retsema JA, Girard AE, Lynch JE, Barth WE. Cp-45899, a β-lactamase inhibitor that extends antibacterial spectrum of β-lactams: initial bacteriological characterizations. Antimicrob Agents Chemother 1978;14:414-419.
8. [8] Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S. Comparative activities of β-lactamase inhibitors YTR830, clavulanate, and sulbactam combined with ampicillin and broad spectrum penicillins against defined β-lactamase-producing aerobic Gram-negative bacilli. Antimicrob Agents Chemother 1986;29:980-985.
9. [9] Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991;324:601-612.
10. [10] Jorgensen JH, Redding JS, Maher LA, Howell AW. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol 1987;25:2105-2113.
11. [11] Kawasaki K, Niini H, Oki T et al. Antibacterial activity of sulbactam and sulbactam/cefoperazone. Chemotherapy (Tokyo) 1984;32 Suppl 4:78-96.
12. [12] de Lencastre H, Figueiredo AM, Urban C, Rahal J, Tomasz A. Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 1991;35:632-639.
13. [13] Murray RP, Jones RN, Allen SD, Erwin ME, Fusch PC, Gerlach EH. Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria. Diagn Microbiol Infect Dis 1993;16:191-203.
14. [14] National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2, 2nd edn. Villanova, PA: NCCLS, 1990.
15. [15] National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A2. Villanova, PA: NCCLS, 1990.
16. [16] National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Third informational supplement, M100-S3. Villanova, PA: NCCLS, 1991.
17. [17] Reshedko G, Vakulenko S, Sidorenko S, Krotova L, Stratchounsky L. Profile of aminoglycoside modifying enzymes in two regions of Russia [abstract 162]. In: Abstracts of the 6th International Congress Infectious Diseases, 1994.
18. [18] Thornsberry C, Brown SD, Yee YC, Bouchillon SK, Marier JK, Rich T. In vitro activity of cefepime and other antimicrobials: survey of European isolates. J Antimicrob Chemother 1993;32 Suppl B:31-54.
19. [19] Urban C, Go E, Mariano N, Rahal JJ. Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible Acinetobacter baumanii. FEMS Microbiol Lett 1995;125:193-197.